Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
vTv Therapeutics Inc. Class A Common Stock logo

vTv Therapeutics Inc. Class A Common Stock Share Price

NASDAQ: VTVTHealthcare

$25.41

-5.48 (17.74%)
BUYSELL

Live vTv Therapeutics Inc. Class A Common Stock Share Price Chart

O H L

vTv Therapeutics Inc. Class A Common Stock Performance Overview

Days Range
▼
$30.36Low
$30.89High

Markets Today

Previous Close$30.08
Open$30.89
Volume12,834
Day's Range$30.36 - $30.89
52W Range$19.50 - $44.00
Market Cap$122.61 M

Historical Performance

1M Returns-9.64
3M Returns-10.05
6M Returns-19.36
1Y Returns+31.41
5Y Returns-53.29
10Y Returns-88.96

vTv Therapeutics Inc. Class A Common Stock Fundamentals

Market Cap$122.61 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.70
EPS TTM$-1.05
Quarterly Earnings Growth YOYN/A
PB Ratio1.55
EBITDA$-32.93 M
Profit MarginN/A
Market Cap$122.61 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.70
EPS TTM$-1.05
Quarterly Earnings Growth YOYN/A
PB Ratio1.55
EBITDA$-32.93 M
Profit MarginN/A

vTv Therapeutics Inc. Class A Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$36.84 M$0
Gross Profit +$0$0$0$0$36.84 M$0
Operating Income -$6.50 M-$7.72 M-$10.70 M-$8.02 M$23.26 M-$13.93 M
EBITDA -$6.49 M-$7.72 M-$10.70 M-$8.02 M$23.26 M-$13.93 M
Interest Expense $0$0-$5.00 K-$1.00 K$0$0
Depreciation $9.00 K$3.00 K$2.00 K$2.00 K$1.00 K$1.00 K
Income Before Tax -$6.22 M-$7.38 M-$10.35 M-$7.14 M$24.13 M-$13.05 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$6.22 M-$7.38 M-$10.35 M-$7.14 M$24.13 M-$13.05 M
Net Profit Margin ----65.51%-

vTv Therapeutics Inc. Class A Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $32.00 K$32.00 K$39.00 K$39.00 K$39.00 K$39.00 K
Reserve & Surplus -$304.81 M-$310.86 M-$319.55 M-$326.69 M-$302.56 M-$315.61 M
Non-Current Liabilities $18.81 M$18.75 M$18.79 M$18.82 M$1.97 M$1.94 M
Current Liabilities $4.32 M$5.29 M$10.16 M$6.64 M$6.88 M$7.02 M
Total Liabilities $23.13 M$24.04 M$28.95 M$25.46 M$8.85 M$8.96 M
Fixed Assets $19.00 K$16.00 K$14.00 K$0$0$0
Current Assets $31.92 M$26.37 M$99.46 M$89.89 M$98.81 M$87.59 M
Total Assets $32.03 M$26.45 M$99.49 M$89.90 M$98.81 M$87.59 M

vTv Therapeutics Inc. Class A Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$6.22 M-$7.38 M-$10.35 M-$7.14 M$24.13 M-$13.05 M
Operating Cash Flow -$5.69 M-$5.09 M-$5.22 M-$9.25 M$9.15 M-$11.44 M
Investing Cash Flow $0$0$0$0$0$0
Financing Cash Flow $0-$42.00 K$77.80 M-$321.00 K$0$0
Change in Cash -$5.69 M-$5.14 M$72.58 M-$9.57 M$9.15 M-$11.44 M

vTv Therapeutics Inc. Class A Common Stock Return Calculator

The vTv Therapeutics Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,946
Invested Amount$10,000
Est. Returns$-6,054
Invest in USA Stock Today

About vTv Therapeutics Inc. Class A Common Stock

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

FAQs

vTv Therapeutics Inc. Class A Common Stock (VTVT) share price as of October 9, 2026 is $25.41. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the vTv Therapeutics Inc. Class A Common Stock (VTVT) Share by opening an international trading account with Angel One.
Purchasing vTv Therapeutics Inc. Class A Common Stock (VTVT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying vTv Therapeutics Inc. Class A Common Stock (VTVT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of vTv Therapeutics Inc. Class A Common Stock (VTVT) or any other US company shares in Angel One for any dollar amount.
The market capitalization of vTv Therapeutics Inc. Class A Common Stock on October 9, 2026, is $122.61 M.
vTv Therapeutics Inc. Class A Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in vTv Therapeutics Inc. Class A Common Stock (VTVT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL